Is bupropion (Wellbutrin) safe to use during the first trimester of pregnancy for depression or smoking cessation?

Bupropion Use in Early Pregnancy

Bupropion can be continued during the first trimester for depression or smoking cessation, as it does not increase the overall risk of major congenital malformations, though it carries a small absolute increase in risk for specific cardiac defects (left ventricular outflow tract obstruction and ventricular septal defects) and diaphragmatic hernia. 1, 2

Overall Safety Profile

• Population-based data show no statistically significant increase in overall major congenital malformations with first-trimester bupropion exposure 2, 3
• The FDA pregnancy exposure registry (675 first-trimester exposures) and retrospective cohort studies (1,213 first-trimester exposures) confirm no increased risk for malformations overall 3
• A prospective study of 136 women exposed to bupropion in the first trimester found zero major malformations among 105 live births 4

Specific Cardiac Risks

• First-trimester exposure is associated with two specific cardiovascular malformations: left ventricular outflow tract obstruction and ventricular septal defects (adjusted OR 2.9; 95% CI 1.5-5.5) 1, 2
• The absolute risk remains low despite the elevated odds ratio, as the background rate of cardiovascular malformations is approximately 1% 3
• The prospectively observed rate of cardiovascular malformations in the pregnancy registry was 1.3% (9/675 exposures), similar to the general population background rate 3

Other Structural Risks

• Possible increased risk for diaphragmatic hernia (adjusted OR 2.77; 95% CI 1.34-5.71), though the absolute risk is very low given the rarity of this condition (population prevalence 0.012%-0.031%) 1, 2

Pregnancy Loss

• One study found a higher rate of spontaneous abortion in the bupropion group compared to controls (20/136 pregnancies, P = 0.009), though this rate remained within the general population range 4
• This finding is consistent with other studies examining antidepressant safety during pregnancy and may reflect confounding by the underlying maternal condition (depression or smoking) 1, 4

Critical Confounding Factor

• Confounding by indication cannot be ruled out in observational studies, as the underlying conditions requiring bupropion (depression or smoking) independently affect pregnancy outcomes 1, 2
• Untreated maternal depression is linked to higher rates of spontaneous abortion, preterm birth, and adverse fetal development 1

Clinical Management Algorithm

Risk-Benefit Discussion

• Do not abruptly discontinue bupropion when it is required for daily functioning, as untreated maternal depression carries its own risks for both mother and fetus 1
• Engage in a risk-benefit discussion regarding continuing at the current well-tolerated, effective dose versus intermittent use 1

Prenatal Monitoring Protocol

• Offer a detailed fetal anatomic ultrasound at 18-20 weeks with focused assessment of cardiac structures (ventricular septum, left ventricular outflow tract, conotruncal anatomy) 2
• Include assessment of the fetal diaphragm during the mid-trimester ultrasound to screen for diaphragmatic hernia 2
• Perform regular fetal growth assessments throughout pregnancy 1
• Conduct routine maternal blood pressure checks while on bupropion therapy 1
• Ensure appropriate maternal weight gain according to gestational guidelines 1

Smoking Cessation Considerations

• The U.S. Preventive Services Task Force reports insufficient evidence to support bupropion's effectiveness for tobacco cessation or for improving perinatal outcomes in pregnant women 1
• One small randomized trial (n=65) showed bupropion reduced cravings and withdrawal symptoms during treatment but found no significant difference in abstinence rates at the end of pregnancy (10% vs 3%, P = 0.328) 5

Alternative Considerations

• If switching antidepressants is considered, sertraline is first-line due to its established safety profile, minimal excretion in breast milk, and no increased risk of cardiac malformations in large population-based studies 6
• Transition directly from bupropion to sertraline without a washout period if switching is necessary to prevent depressive relapse 6

Common Pitfalls to Avoid

• Do not discontinue effective treatment solely due to pregnancy, as the risks of untreated depression often outweigh the small absolute risks of medication exposure 1
• Do not use bupropion as first-line for smoking cessation during pregnancy given insufficient evidence of efficacy for this indication 1
• Do not skip targeted fetal cardiac surveillance at 18-20 weeks, as this is the critical window for detecting the specific cardiac defects associated with bupropion 2